Metraipolis › archive › dc_87c85316cf45

Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches — Europe PMC PMID:42239945

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42239945
DOI
10.3389/fmed.2026.1777235
License (as archived)
solo-consultazione
Archived
2026-10-07T23:32:32.392Z
SHA-256 of the archived text
385c7b3635e16cf92174ddd1dab8366a8c0f8bbb700ba9281864ca8274d382f8
Stable URL of this page
https://metraipolis.com/documento/dc_87c85316cf45

How to cite

Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches — Europe PMC PMID:42239945 — Europe PMC (en), https://europepmc.org/article/MED/42239945 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_87c85316cf45 (Metraipolis archive dc_87c85316cf45, sha256 385c7b3635e16cf92174ddd1dab8366a8c0f8bbb700ba9281864ca8274d382f8)
BibTeX
@misc{dc87c85316cf45,
  title = {Exploring the celecoxib-cervical cancer relationship using in vitro, network pharmacology, and Mendelian randomization approaches — Europe PMC PMID:42239945},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42239945},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_87c85316cf45; sha256 385c7b3635e16cf92174ddd1dab8366a8c0f8bbb700ba9281864ca8274d382f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42239945. Agents can read the archived copy with the MCP tool read_document.